GSK’s Exdensur receives Japan’s MHLW approval for severe asthma and chronic rhinosinusitis with nasal polyps: London, UK Wednesday, January 7, 2026, 10:00 Hrs [IST] GSK plc an ...
Celebrities often face rumors about cosmetic procedures, but many aren’t afraid to respond. Recently, Andy Cohen addressed ...
What Changed in the Amgen Story Amgen’s fair value estimate has been adjusted slightly, moving from about US$322.88 per share ...
GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...
Savannah Guthrie has shared an update after undergoing vocal cord surgery. The 'Today' co-anchor announced on Dec. 19 that ...
The longtime co-anchor isn't the only familiar face to have successful vocal cord surgery. Guthrie's TODAY colleague, ...
GSK has received approval from China’s National Medical Products Administration for Nucala as an add-on maintenance therapy for adults with inadequately controlled COPD and elevated blood eosinophils.